Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
900.16
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Regeneron Pharma Says Fewer Aflibercept Injections Maintains Vision, Anatomic Improvements In Diabetic Macular Edema
July 31, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the first presentation of two-year (96 weeks) results from the pivotal PHOTON trial of aflibercept 8 mg with 12- and 16-week dosing regimens,...
Via
Benzinga
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
July 26, 2023
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.
Via
InvestorPlace
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen
Via
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
July 24, 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.
Via
InvestorPlace
Why Are Kodiak Sciences Shares Trading Lower Today?
July 24, 2023
Kodiak Sciences Inc (NASDAQ: KOD) shares are tumbling after the company released topline results from three Phase 3 studies of tarcocimab tedromer, a novel antibody biopolymer conjugate, for...
Via
Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
July 19, 2023
Via
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
July 17, 2023
Via
Benzinga
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
July 11, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
Regeneron Pharmaceuticals Earnings Preview
August 02, 2023
Via
Benzinga
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $58,000 Today
August 01, 2023
Via
Benzinga
P/E Ratio Insights for Regeneron Pharmaceuticals
July 28, 2023
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
July 07, 2023
Via
Benzinga
Is Regeneron Stock a Buy After a Regulatory Blow?
July 07, 2023
Don't write this company's eulogy too fast.
Via
The Motley Fool
Alnylam Says Single Injection Of RNAi Therapy Cuts Alzheimer's-Linked Proteins By 65%, Stock Soars
July 17, 2023
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced updated interim results for the ongoing single ascending dose portion of the Phase 1 study of ALN-APP for Alzheimer's disease and
Via
Benzinga
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
July 06, 2023
Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at...
Via
Benzinga
Check Out What Whales Are Doing With REGN
July 03, 2023
Via
Benzinga
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
July 03, 2023
Via
Benzinga
Why Regeneron Pharmaceuticals Stock Dipped This Week
June 29, 2023
A key regulatory setback is weighing on the biotech's stock.
Via
The Motley Fool
Is Regeneron's Stock in Trouble After This FDA Rejection?
July 06, 2023
The company's growth rate has been slowing sharply in recent quarters, and Eylea generates the bulk of its product revenue.
Via
The Motley Fool
Biotech Blues: Stay Balanced Through July Earnings Season
July 05, 2023
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.
Via
Talk Markets
The 3 Best Biotech Stocks to Buy In July
July 05, 2023
With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.
Via
InvestorPlace
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
June 30, 2023
Major indexes rebounded strongly and many stocks flashed buy signals.
Via
Investor's Business Daily
What Will Amgen Buy Next?
June 29, 2023
The biotech could pursue these two budget-friendly targets.
Via
The Motley Fool
Why Catalent Stock Flopped Today
June 28, 2023
The company takes the fall for a failed drug application.
Via
The Motley Fool
Why Regeneron Stock Is Trading Lower Today
June 28, 2023
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares continue to fall Wednesday after news Tuesday that the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.